tiprankstipranks
Trending News
More News >
Halozyme Therapeutics (GB:0J2O)
LSE:0J2O
UK Market
Advertisement

Halozyme (0J2O) Technical Analysis

Compare
1 Followers

Technical Sentiment

Overall Consensus
Buy
10Bullish
6Neutral
6Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Halozyme Therapeutics’s (0J2O) Moving Averages Convergence Divergence (MACD) indicator is -1.76, suggesting Halozyme Therapeutics is a Buy.
Halozyme Therapeutics’s (0J2O) 20-Day exponential moving average is 68.81, while Halozyme Therapeutics’s (0J2O) share price is $66.96, making it a Sell.
Halozyme Therapeutics’s (0J2O) 50-Day exponential moving average is 68.80, while Halozyme Therapeutics’s (0J2O) share price is $66.96, making it a Sell.

Halozyme (0J2O) Pivot Points

Oct 22, 2025, 01:49 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
65.29
65.71
66.21
66.63
67.13
67.55
68.05
Fibonacci
65.71
66.06
66.28
66.63
66.98
67.20
67.55
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Halozyme (0J2O) Moving Averages

Oct 22, 2025, 01:49 AM
Period
Simple
Exponential
MA5
66.64Buy
66.66Buy
MA10
65.90Buy
67.16Buy
MA20
69.98Sell
68.81Sell
MA50
71.16Sell
68.80Sell
MA100
63.51Buy
65.75Buy
MA200
60.92Buy
61.80Buy
Halozyme Therapeutics’s (0J2O) 10-Day exponential moving average is 67.16, while Halozyme Therapeutics’s (0J2O) share price is $66.96, making it a Buy.
Halozyme Therapeutics’s (0J2O) 100-Day exponential moving average is 65.75, while Halozyme Therapeutics’s (0J2O) share price is $66.96, making it a Buy.
Halozyme Therapeutics’s (0J2O) stock price is $66.96 and Halozyme Therapeutics’s (0J2O) 50-day simple moving average is 71.16, creating a Sell signal.
Halozyme Therapeutics’s (0J2O) stock price is $66.96 and Halozyme Therapeutics’s (0J2O) 100-day simple moving average is 63.51, creating a Buy signal.
Halozyme Therapeutics’s (0J2O) stock price is $66.96 and Halozyme Therapeutics’s (0J2O) 200-day simple moving average is 60.92, creating a Buy signal.

Halozyme (0J2O) Technical Indicators

Oct 22, 2025, 01:49 AM
Name
Value
Implied Action
RSI (14)
42.94
Neutral
STOCH (9,6)
51.70
Neutral
STOCHRSI (14)
23.61
Neutral
MACD (12,26)
-1.76
Buy
ADX (14)
29.89
Neutral
Williams %R
-72.34
Buy
CCI (14)
-50.91
Neutral
ATR (14)
2.11
-
Ultimate Oscillator
45.81
Neutral
ROC
-8.41
Sell
Halozyme Therapeutics’s (0J2O) Relative Strength Index (RSI) is 42.94, creating a Neutral signal.
Halozyme Therapeutics’s (0J2O) Trend Strength Indicator (ADX) is 29.89, creating a Neutral signal.
Halozyme Therapeutics’s (0J2O) Commodity Channel Index (CCI) is -50.91, creating a Neutral signal.
Halozyme Therapeutics’s (0J2O) Price Rate of Change (ROC) is -8.41, creating a Sell signal.

FAQ

Is 0J2O a Buy, Hold, or Sell?
Based on 0J2O’s technical indicators, 0J2O is a Buy.
    What is 0J2O’s RSI (14)?
    0J2O’s RSI (14) is 42.94, which suggests 0J2O is a Neutral.
      What is 0J2O’s MACD?
      0J2O’s MACD is -1.76, which suggests 0J2O is a Buy.
        What is 0J2O’s 5-day moving average?
        0J2O’s 5-day moving average is 66.64, which suggests 0J2O is a Buy.
          What is 0J2O’s 20-day moving average?
          0J2O 20-day moving average is 69.98, which suggests 0J2O is a Sell.
            What is 0J2O’s 50-day moving average?
            0J2O’s 50-day moving average is 71.16, which suggests 0J2O is a Sell.
              What is 0J2O’s 200-day moving average?
              0J2O’s 200-day moving average is 60.92, which suggests 0J2O is a Buy.
                What is 0J2O’s Williams % R (14)?
                0J2O’s Williams % R (14) is -72.34, which suggests 0J2O is a Buy.
                  What is 0J2O’s CCI (14)?
                  0J2O’s CCI (14) is -50.91, which suggests 0J2O is a Neutral.
                    What is the share price of Halozyme Therapeutics?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis